ASCO: J&J eyes Darzalex convenience, safety boost with subcutaneous win

3rd June 2019 Uncategorised 0

Right now, the first infusion of Johnson & Johnson multiple myeloma fighter Darzalex can take between seven and eight hours. But data on a new formulation could be a game changer.

More: ASCO: J&J eyes Darzalex convenience, safety boost with subcutaneous win
Source: fierce